Premium
Brentuximab vedotin in multifocal cutaneous anaplastic large cell lymphoma in a patient with human immunodeficiency virus following Hodgkin lymphoma
Author(s) -
Wolf S.,
Goiriz R.,
Dhairyawan R.,
Paige D.,
Rizvi H.,
Haroon A.,
Montoto S.
Publication year - 2019
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.13824
Subject(s) - brentuximab vedotin , anaplastic large cell lymphoma , lymphoma , medicine , human immunodeficiency virus (hiv) , hodgkin lymphoma , oncology , virology , dermatology , pathology
Click here for the corresponding questions to this CME article.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom